Tradestie Institutional Equity Comparison Engine
ARVN vs ALEC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ALEC Overall Edge
ALEC Captures Institutional Edge (4โ0 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Alector, Inc. Common Stock (ALEC) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ARVN trades at 17.9x Forward P/E with -10.1% operating margin (-98.8% YoY revenue) versus ALEC at 8.5x Forward P/E and 21.8% operating margin (+4895.9% YoY). In options structure, ARVN sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro) against ALEC sits in CONSOLIDATION (9th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
ALEC
ARVN 17.9x vs ALEC 8.5x Fwd P/E
Growth & Margin Winner
ALEC
Op Margin -10.1% vs 21.8% ยท YoY -98.8% vs +4895.9%
Momentum & Technical Winner
ALEC
1Y -33.4% vs +112.1% ยท 52W Pos 5% vs 83%
Options & Structure Winner
ALEC
BREAKDOWN (25th %ile IV) vs CONSOLIDATION (9th %ile IV)
ARVN
NASDAQ
Arvinas, Inc
Pharmaceutical Preparations
$6.74
-1.17% 1D
Market Cap
$449.9M
1M Return
-3.3%
1Y Return
-33.4%
Forward P/E
17.9x
Unified AI Score
52.9 / 100
HOLD
Tech 54.0
Fund 59.0
Flow 71.0
Mom 54.0
ALEC
NASDAQ
Alector, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$2.54
+0.2% 1D
Market Cap
$364.7M
1M Return
+38.32%
1Y Return
+112.08%
Forward P/E
8.5x
Unified AI Score
37.0 / 100
SELL
Tech 50.0
Fund 34.0
Flow 64.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ARVN -33.4%
ALEC +112.08%
Spread: +145.48 pp (ALEC Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ARVN Revenue | ALEC Revenue | ARVN Op. Margin | ALEC Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $10M | $30M | -306.3% | -208.3% | ALEC |
| FY2019 | $20M | $20M | -281.4% | -539.2% | ARVN |
| FY2020 | $20M | $20M | -554.1% | -925.1% | ARVN |
| FY2021 | $50M | $210M | -403.4% | -18.0% | ALEC |
| FY2022 | $130M | $130M | -200.3% | -103.2% | ALEC |
| FY2023 | $80M | $100M | -511.5% | -156.3% | ALEC |
| FY2024 | $260M | $100M | -95.0% | -144.2% | ARVN |
| FY2025 | $260M | $20M | -45.1% | -741.3% | ARVN |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ARVN | ALEC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $449.9M | $364.7M | Larger Scale | ARVN |
| Trailing P/E Ratio Valuation | 17.9x | 6.6x | Lower Multiple | ALEC |
| Forward P/E Ratio Valuation | 17.9x | 8.5x | Lower Multiple | ALEC |
| Revenue Growth (YoY) Growth | -98.8% | +4895.9% | Higher Growth | ALEC |
| Operating Margin (TTM) Profitability | -10.1% | 21.8% | Higher Margin | ALEC |
| Net Profit Margin Profitability | -3.5% | 23.9% | Higher Margin | ALEC |
| Return on Equity (ROE) Capital Efficiency | -1.8% | 47.5% | Higher ROE | ALEC |
| 52-Week Range Position Momentum | 5% ($6โ$15) | 83% ($1โ$3) | Stronger Trend | ALEC |
| Beta / 30D Volatility Risk Regime | 1.40ฮฒ ยท 66% Vol | 1.58ฮฒ ยท 95% Vol | Lower Realized Risk | ARVN |
| Unified Institutional Score Composite Signal | 52.9 / 100 (HOLD) | 37.0 / 100 (SELL) | Higher Composite | ARVN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ARVN vs ALEC Buy Guide
ARVN
BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
25th %ile
IV Regime
Balanced (25thโ60th %ile)
ALEC
CONSOLIDATION
52d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
9th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ARVN nor ALEC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.